Department of Nephrology and Rheumatology, Aichi Medical University, Nagakute, Japan.
Department of Nephrology, Nagoya University Graduate School of Medicine, Nagoya, Japan.
Am J Physiol Renal Physiol. 2022 Dec 1;323(6):F654-F665. doi: 10.1152/ajprenal.00396.2021. Epub 2022 Sep 29.
Cardiovascular disease is the most common comorbidity in patients with chronic kidney disease (CKD), affecting both their prognosis and quality of life. Cardiac fibrosis is common in patients with CKD with left ventricular diastolic dysfunction, and it is associated with increased risk of heart failure and mortality. Recent evidence suggests that high salt intake activates immune responses associated with local accumulation of sodium. We reported that high salt intake promotes cardiac inflammation in subtotal nephrectomized (Nx) mice. We investigated the effects of administration of MR16-1, a rat anti-mouse monoclonal interleukin (IL)-6 receptor antibody, in Nx mice with salt loading (Nx-salt). Expression of monocyte chemoattractant protein-1, tumor necrosis factor-α, IL-1β, and IL-6 mRNAs and macrophage infiltration was significantly reduced in the heart of Nx-salt mice treated with MR16-1 (Nx-salt-MR16-1) compared with Nx-salt mice treated with control rat rat IgG1 (Nx-salt-rat IgG1). Correspondingly, cardiac fibrosis was significantly attenuated in Nx-salt-MR16-1 mice compared with Nx-salt-rat IgG1 mice. Furthermore, in the heart of Nx-salt-MR16-1 mice, expression of mRNA for nicotinamide adenine dinucleotide phosphate oxidase-2, an oxidative stress marker, was significantly downregulated compared with Nx-salt-rat IgG1 mice. Increases in cardiac metabolites, including histidine and γ-butyrobetaine, were also reversed by IL-6 blockade treatment. In conclusion, IL-6 blockade exerts anti-inflammatory, antifibrotic, and partial antioxidative effects in the heart of Nx-salt mice. In the present study, IL-6 blockade exerted anti-inflammatory, antifibrotic, and partial antioxidative effects on the hearts of mice with CKD on a high-salt diet. Therefore, IL-6 potentially mediates cardiac fibrosis induced by high salt intake in patients with CKD, a finding with therapeutic implications. Of note, the next therapeutic implication may simply be the reinforcement of low-salt diets or diuretics and further research on the anti-inflammatory effects of these measures rather than IL-6 blockade with high-salt diet.
心血管疾病是慢性肾脏病(CKD)患者最常见的合并症,影响其预后和生活质量。左心室舒张功能障碍的 CKD 患者常发生心肌纤维化,且与心力衰竭和死亡率增加相关。最近的证据表明,高盐摄入会激活与局部钠积累相关的免疫反应。我们报道高盐摄入可促进部分肾切除(Nx)小鼠的心脏炎症。我们研究了在盐负荷(Nx-salt)的 Nx 小鼠中给予 MR16-1(一种抗鼠单克隆白细胞介素(IL)-6 受体抗体)的作用。与用对照大鼠 IgG1(Nx-salt-rat IgG1)处理的 Nx-salt 小鼠相比,用 MR16-1 处理的 Nx-salt 小鼠(Nx-salt-MR16-1)的心脏中单核细胞趋化蛋白-1、肿瘤坏死因子-α、IL-1β 和 IL-6 mRNA 的表达以及巨噬细胞浸润明显减少。相应地,与 Nx-salt-rat IgG1 小鼠相比,Nx-salt-MR16-1 小鼠的心肌纤维化明显减轻。此外,在 Nx-salt-MR16-1 小鼠的心脏中,与 Nx-salt-rat IgG1 小鼠相比,烟酰胺腺嘌呤二核苷酸磷酸氧化酶-2(一种氧化应激标志物)的 mRNA 表达明显下调。IL-6 阻断治疗还逆转了心脏代谢物(包括组氨酸和γ-丁基甜菜碱)的增加。总之,IL-6 阻断在 Nx-salt 小鼠的心脏中发挥抗炎、抗纤维化和部分抗氧化作用。在本研究中,IL-6 阻断在高盐饮食的 CKD 小鼠心脏中发挥抗炎、抗纤维化和部分抗氧化作用。因此,IL-6 可能介导 CKD 患者高盐摄入引起的心肌纤维化,这具有治疗意义。值得注意的是,下一步的治疗意义可能只是加强低盐饮食或利尿剂,并进一步研究这些措施的抗炎作用,而不是用高盐饮食阻断 IL-6。